Bi

Biologics

Biologics: Targets and Therapy is an international, peer-reviewed, open access journal focused on the pathophysiological rationale for and clinical application of biologic agents and biosimilars in autoimmune diseases, cancers, and other pathologies with identifiable molecular targets. Topics include gene therapy, cell therapy, antibody-based therapy, blood components, vaccines, hormones, cytokines and growth factors, toxins, and peptides. The journal publishes original research, reviews, basic science, clinical studies, and commentaries, does not accept study protocols, no longer considers meta-analyses, and considers case reports only when they make a valuable and original contribution to the literature.

Looking to publish in Biologics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Medicine, Research & Experimental
Impact Factor 3.4
Quartile Q2
Open Access Type Open
ISSN 1177-5475
eISSN 1177-5491
Invitation Only No
Cost Range Invited reviews are exempt from paying any publication processing fee.

Submission Instructions

Biologics accepts the following article types. Click on an article type to view submission instructions.

Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Reviews commonly use an unstructured abstract.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3-6 keywords, and the abstract must be unstructured in one paragraph outlining the purpose of the paper, results obtained, and conclusions.
References References must follow American Medical Association (AMA) style. References must be cited sequentially in superscript numerals, numbered in citation order, use PubMed journal abbreviations, list all authors when there are six or fewer, and list the first three authors followed by "et al." when there are more than six.
Figures & Tables Figures must be provided separate from the manuscript, while tables may be included in the manuscript or submitted as separate files. Figures must not be pasted into the manuscript and tables must be submitted in editable format rather than as images.
Reformat to Biologics using Livewrite Premium

Invited Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract must be unstructured and presented in one paragraph.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3–6 keywords, and any use of AI must be acknowledged in the paper.
References References must follow American Medical Association (AMA) style. References must be cited sequentially in superscript Arabic numerals, numbered in citation order, use PubMed journal abbreviations, list all authors when there are six or fewer, and list the first three authors followed by et al. when there are more than six.
Figures & Tables Figures must be provided separate from the manuscript, while tables may be included in the manuscript or submitted as separate files. Figures must not be pasted into the manuscript, and tables must be submitted in editable format rather than as images.
Reformat to Biologics using Livewrite Premium

Original Research Papers

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Original Research Papers. Abstract must not exceed 300 words. Abstract must be structured.
Manuscript Manuscript typically includes Abstract, Introduction, Methods, Results, Discussion, and Conclusion sections. Manuscript must include 3 to 6 keywords, and authors must acknowledge the use of AI in the paper.
References References must follow American Medical Association (AMA) style. References must be cited sequentially in the text, tables, and legends using superscript Arabic numerals, numbered in the reference list in citation order, with PubMed journal abbreviations and all authors listed for six or fewer authors or the first three followed by "et al." for more than six.
Figures & Tables Figures must be provided separate from the manuscript, while tables may be provided within the manuscript or as separate files. Figures must not be pasted into the manuscript, tables must be submitted in editable format rather than as images, and both figures and tables must include legends or keys when needed to explain labels, symbols, or formatting.
Reformat to Biologics using Livewrite Premium

Meta-Analyses

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract must be unstructured and presented in one paragraph.
Manuscript Manuscript must include the sections Introduction, Material and Methods, Results, Discussion, and Conclusions. Manuscript must include 3 to 6 keywords, and authors must acknowledge the use of AI in the paper.
References References must follow American Medical Association (AMA) style. References must be cited sequentially in superscript Arabic numerals, listed in citation order, use PubMed journal abbreviations, list all authors when there are six or fewer, and list the first three authors followed by “et al.” when there are more than six.
Figures & Tables Figures must be uploaded separately from the manuscript, while tables may be included within the manuscript or submitted as separate files. Figures and tables must be cited in the text, figures must not be pasted into the manuscript, and tables must be submitted in editable format rather than as images.
Reformat to Biologics using Livewrite Premium

Case Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 300 words. Abstract must be unstructured and presented in one paragraph.
Manuscript Case Report must describe a single patient case and include detailed information on the patient's symptoms, signs, diagnosis, treatment, and follow-up. Manuscript must include 3 to 6 keywords.
References References must follow American Medical Association (AMA) style. References must be cited sequentially in the text, tables, and legends using superscript Arabic numerals, numbered in citation order in the reference list, with PubMed journal abbreviations and all authors listed for six or fewer authors or the first three followed by "et al." for more than six authors.
Figures & Tables Figures must be provided separate from the manuscript, while tables may be included in the manuscript or submitted as separate files. Figures and tables must be cited in the text, figures must not be pasted into the manuscript, tables must be editable rather than images, and legends or keys must identify any labels, symbols, or indicators used.
Reformat to Biologics using Livewrite Premium

Recent Publications

Clinical Evaluation of Allergen Immunotherapy for Allergic Asthma

Francesco Catamerò, Simone Foti Randazzese, Davide Caimmi, Giovanni Paoletti, Giorgio Walter Canonica, Enrico Heffler, Andrea Giovanni Ledda, Stefano Del Giacco, Giulia Anna Maria Luigia Costanzo, Giuseppe Guida, Fabio Luigi Massimo Ricciardolo, Francesca Bertolini, Remo Poto, Rory Chan, Gilda Varricchi, Mattia Giovannini

10.2147/btt.s624174
View Publication

What’s New and What’s Next for Emicizumab for the Treatment of Hemophilia A?

Johnny N Mahlangu

10.2147/btt.s650788
View Publication

Beyond Eczema Control: Long-Term Outcomes of Dupilumab Therapy in Six Patients with Netherton Syndrome

Kamila Zawadzińska-Halat, Magdalena Stec, Katarzyna Poznańska-Kurowska, Maciej Pastuszczak

10.2147/btt.s638248
View Publication

Real-World Outcomes of a Non-Medical Switch to Adalimumab-Atto Biosimilar: Safety, Effectiveness, and Treatment Persistence in an Adult Saudi Tertiary Care Population

Alhanouf Almousa, Mohamed Ahmed, Rayd Abdulaziz Almehizia, Meshal Aldurayhim, Gamal Mohamed, Almutairdi Abdulelah, Yousef Binamer, Ahmed Alshaikh

10.2147/btt.s612345
View Publication

Apatinib Plus PD-1 Blockade versus Chemotherapy After Prior Immunotherapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Cohort Study

Rui-Xin Li, Hong-Wei Yang, Yun-Fei Zhang, Xin-Yu Liu

10.2147/btt.s639872
View Publication

Frequently asked questions

How long does it take to publish?

Accelerated Publication; rapid reporting of original research, reviews, basic science, clinical studies and commentaries.

Reformat to Biologics using Livewrite Premium

Is a cover letter required?

A point-by-point covering letter is required when submitting a revised manuscript after editorial review.

Reformat to Biologics using Livewrite Premium

What are the publication costs?

Invited reviews are exempt from paying any publication processing fee.

Reformat to Biologics using Livewrite Premium

Research Topics

Rheumatoid Arthritis Research and Therapies Monoclonal and Polyclonal Antibodies Research Biosimilars and Bioanalytical Methods Psoriasis: Treatment and Pathogenesis Systemic Lupus Erythematosus Research Spondyloarthritis Studies and Treatments Inflammatory Bowel Disease Chronic Lymphocytic Leukemia Research Lung Cancer Treatments and Mutations Autoimmune and Inflammatory Disorders Research Immunotherapy and Immune Responses Colorectal Cancer Treatments and Studies HER2/EGFR in Cancer Research CAR-T cell therapy research Autoimmune Bullous Skin Diseases Asthma and respiratory diseases Microscopic Colitis Cancer Treatment and Pharmacology Cancer Immunotherapy and Biomarkers Multiple Sclerosis Research Studies Platelet Disorders and Treatments Chronic Myeloid Leukemia Treatments T-cell and B-cell Immunology Acute Lymphoblastic Leukemia research Urticaria and Related Conditions

Related Journals

II
Innate Immunity SAGE Publishing
MP
Molecular Pharmaceutics American Chemical Society
JO
Journal of Hepatocellular Carcinoma Dove Medical Press
Va
Vaccine Elsevier BV
Bi
Biomedicines Multidisciplinary Digital Publishing Institute
Ma
mAbs Landes Bioscience